论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
大肠腺瘤复发评分系统的建立与验证
Authors Xi X, Fu Z, Liu T, Lin Y, Wu W, Li J, Luo M, Zhang B
Received 18 April 2021
Accepted for publication 29 September 2021
Published 9 November 2021 Volume 2021:14 Pages 4545—4552
DOI https://doi.org/10.2147/RMHP.S316408
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Jongwha Chang
Objective: The purpose of this study was to establish and verify a risk-scoring system for colorectal adenoma recurrence.
Methods: A total of 359 patients with colorectal adenoma who underwent polypectomy from October 2017 to December 2018 were included in this retrospective study. Information including taking traditional Chinese medicine, demographic characteristics, adenoma characteristics were collected. The patients will review the colonoscopy one year after surgery. The patients were divided into a modeling cohort (216 cases) and a model validation cohort (143 cases) according to the ratio of 6:4. Modeling and model verification were performed by logistic regression, ROC curve, nomogram (calibration chart) and other methods.
Results: After adjusting for confounding factors by logistic regression, it was found that taking Chinese medicine, the number, size, site, pathological type and morphology of adenoma were independent influencing factors for the recurrence of colorectal adenoma. The area under the ROC curve (AUC) in the model validation cohort of established risk scoring system was 0.771 (95% CI: 0.694– 0.847), indicating that there was good consistency.
Conclusion: The established risk prediction model of colorectal adenoma recurrence and its risk scoring system performed well and had high predictive value.
Keywords: colorectal adenoma, recurrence, prediction model, risk scoring system